Diane Iler-Smith returned to Biolumina as senior VP, executive creative director. Iler-Smith has more than 20 years of strategic and creative leadership experience in healthcare communications, including extensive global and US branding and launch expertise. She leads all creative assignments at the agency.
Intouch Solutions continues to elevate employees across the agency.
I recently read an article about how awards do not really matter in the advertising industry. The author basically said the only thing advertising is supposed to do is sell stuff. I agree, but not completely. Awards do matter.
So what is leadership? I believe leadership consists of three components: commitment, integrity, and respect.
The U.S. regulatory landscape will continue to evolve in 2018, potentially adding complexity and compliance challenges to the life sciences industry. Recent changes are being driven by nationwide concerns with prescription drug abuse, which is prompting many states to enforce new mandates and programs regarding drug practices.
Two thirds, or 67 percent, of respondents have encountered lower turnover from direct hire sales reps as opposed to CSO reps, according to a recent survey of executives by Best Practices LLC.
As the landscape for pharmaceutical marketing continues to evolve, multi-channel marketers have been investigating opportunities to advertise their products and services, and provide clinical decision support information within electronic health records (EHRs). For the first time, healthcare marketers can impact provider-patient interactions by delivering messages directly at the point of care. EHRs have over 90 percent adoption with healthcare professionals (HCPs) in the U.S., while certain practice specialties reach nearly ubiquitous (99 percent) adoption, thereby creating an exceptional opportunity not to be missed!
Steve Sabus was named general manager of Astellas Pharma Canada (APCA), effective April 1, 2018. In his new role, he will lead business operations in the country.
Uwe Röhrhoff was named CEO of Perrigo Company following the retirement of John T. Hendrickson.